DAWNRAYS PHARMA (02348) repurchased 232,000 shares on November 2 for HK$213,600.
DAWNRAYS PHARMA (02348) announced that on November 2, 2026, the company repurchased 232,000 shares for HK$213,600, at a repurchase price of HK$0.915-0.925 per share.
DAWNRAYS PHARMA (02348) announced that on November 2, 2026, the company repurchased 232,000 shares for HK$213,600, at a repurchase price of HK$0.915-0.925 per share.
Related Articles
YCIC Eco-Technology (002200.SZ): Consortium wins bid for the historical waste residue remediation project around agricultural land in Maguan County
Travel demand remains resilient! Marriott (MAR.US) Q3 profit and RevPAR beat expectations, full-year outlook raised.
SAINT BELLA GP (02508) repurchased 1.3295 million shares on November 2 for approximately HK$2.8872 million.
YCIC Eco-Technology (002200.SZ): Consortium wins bid for the historical waste residue remediation project around agricultural land in Maguan County
Travel demand remains resilient! Marriott (MAR.US) Q3 profit and RevPAR beat expectations, full-year outlook raised.
SAINT BELLA GP (02508) repurchased 1.3295 million shares on November 2 for approximately HK$2.8872 million.
